Feedback Share Discussion Threads

[ducatiman] 22/3/2021 16:39

It has’nt strengthened the share price LR2, they must have a few to shift at this level.
Hopefully revenue declaring news soon to change the dynamics.
Cash position must be good as they are giving £5k to charity for filling out a questionnaire.

[lr2] 22/3/2021 16:34

Yes, today's trade timed at 13:56:39. Nearly April, we should be buzzing soon.

[ducatiman] 22/3/2021 16:24

Is it a trade from today LR2? If so they must have plenty to sell as I can only sell 200k at 1.21

[lr2] 22/3/2021 16:20

Davy? Cooeee Davy? Was it you?

[digger2779] 22/3/2021 16:11

Not me gov. I don't have that many.

[ducatiman] 22/3/2021 16:02

Not me but I can’t sell many currently, if I wanted to.

[lr2] 22/3/2021 15:58

OK, own up, who bought the 1.58 mil that just showed up on a delayed trade?

[herb clark] 22/3/2021 10:54

Will we ever get news?

[chopper harris1] 22/3/2021 10:10

Would be nice to have even a fraction of the positive share price activity being enjoyed over at FUM.

We can but hope and dream.

[ged5] 19/3/2021 14:12

Tweet from Dr Venkat earlier today:-

Secure, certified, high quality communication tool is a must for delivering high quality patient care! Long time & hard work to get to this stage but finally out with a world class product! Very proud of @BleepaMe @FBKmed

He's obviously a man who embraces new technology. Perhaps a good man to have on board.

This from earlier in the year:-

Dr. Venkat Ramana Sudigali said: “I am a classic example of a doctor who uses technology on daily basis. Teleradiology was well established before covid-19. PACS came in a big way in early millennium. With PACS being established, it was a great step towards embracing technology. Images can be transformed to any parts of the world. Technology is helping patients in timely diagnosis and treatment in appropriate way. Post COVID-19, there has been acceleration in innovations. AI and ML are looked more seriously.”

“Patients are now embracing technology, logging to website and mobile apps. They are willing to be treated by consultants who are not in front of them. It saves patients’ crucial time in travelling. Moreover it is cost effective as well.”

[lr2] 19/3/2021 12:01

Thanks for the info Ged. I've not seen the share premium account used like that before.

[ged5] 19/3/2021 11:15

Hi LR2.

I think this is the reason:-

Cancellation of Share Premium Account

At the last Annual General Meeting, shareholders voted to cancel share premium to create a pool of distributable reserves to the amount of £23.4 million. This is a regular occurrence for share premium created more than three years ago to enable the continued payment of dividends and buyback of shares. A further resolution to cancel share premium is being proposed at this year’s Annual General Meeting.

I note the fund is now closed to new investors.

[lr2] 18/3/2021 19:05

Ged, re your post #7548 a couple of days ago, I've just spotted this RNS from Octopus today.

"Octopus AIM VCT 2 plc announces that on 18 March 2021 the Company purchased for cancellation 555,254 Ordinary shares at a price of 91.7p per share."



They appear to do something similar most months lately.

Any thoughts?

[ducatiman] 18/3/2021 09:54

It is getting a tad irksome Yump, is it not?

[yump] 18/3/2021 09:31

I’d bet my holding the answer is ‘no’

Theres nothing to expand so thats just the usual world beating talk.

[ducatiman] 18/3/2021 09:23

Again from Twitter:-
“ Find out about our expansion into the India market”.
Is there something they are not telling us?

[lr2] 17/3/2021 14:32

About that give or take a fortnight.

Here's something new for you. Video 29 has just dropped on BleepaVision.

[ged5] 17/3/2021 14:27

Thanks. So nothing new then.

Looks like they are still in the process of updating the website.

What do you reckon? 3 weeks before any contract news?

[lr2] 17/3/2021 14:14

Hi Ged, I can't remember when I last posted any key facts list but the 36.3 weeks comes from the Final Results of last October.
__________________________________

· The average time from point of referral to clinician review was reduced from 2.1 days to 0.4 days by Bleepa

· The referral process was able to be completely automated by Bleepa, having previously required administrative time to process each referral and the referral process was both digitally stored and auditable.

· Bleepa reduced the time taken, on average, for clinicians to access the clinical information that they needed about a patient from 5.47 minutes to 1.04 minutes, saving on average 4.43 minutes of clinician time per referral.

· Bleepa reduced the process of replying to referrals by an average of 7.5 minutes per clinical referral over traditional communication processes, such as pagers and telephones.

· Based on the nearly 7,000 referrals performed last year at the Royal Oldham Hospital, it is predicted that Bleepa could save up to 36.3 weeks of clinical time per annum.

[ged5] 17/3/2021 13:32

LR2, you highlighted some key facts in a previous link (I haven't got them to hand). If you can remember them are these different? I don't remember seeing the 36.3 weeks of clinical time per annum released before.

Key Facts

Reduction in Administrative Support One hundred percent of all inpatient respiratory referrals can be managed without admin support freeing time to focus on other tasks.

Response TimesBenchmarking for respiratory inpatient referrals showed that the existing process took on average 2.1 days before the receiving team got to review the referrals.

With the introduction of Bleepa and the removal of the manual administrative steps, referrals are actioned within 0.4 days. This represents a saving of 1.7 days per referral

Releasing Time to Care

A benchmarking audit shows that the process of responding to referrers can take on average 7.5 minutes per referral. The introduction of Bleepa reduces this response time to less than one minute by enabling a receiving doctor to respond using the chat in Bleepa. This results in a clinical time saving of approximately 6.5 minutes per referral.

This equates to 5.6 weeks of a full-time clinician’s time released per annum based on current usage and a prediction of 36.3 weeks of clinical time per annum released if the project is expanded to all other medical teams.

[ged5] 17/3/2021 13:10

They've updated the Bleepa website.

[yump] 17/3/2021 12:52

I think you know the answer to that one !

I wonder how they were recruited - hopefully not 'networked' through a mates connection. I bet they're not cheap either.

[ducatiman] 17/3/2021 09:27

From Twitter:-
We’ve welcomed Siva Ramamoorthy &
@DrVenkatRS
to our team to help grow our presence in the Indian market.
Do we have a presence in the Indian market?

[ducatiman] 16/3/2021 19:22

The company continues to add to its payroll/costs.
It continues to burn the cash at an increasing rate.
As I have said previously only idiots would do this if there was no imminent and substantial revenue.
I cling to the hope that we are being run by businessmen and not spivs in white coats and that Rory Shaw’s and the institutions’ on market purchases were based on some knowledge of what is coming down the line.